0001209191-13-044599.txt : 20130917 0001209191-13-044599.hdr.sgml : 20130917 20130917161343 ACCESSION NUMBER: 0001209191-13-044599 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130916 FILED AS OF DATE: 20130917 DATE AS OF CHANGE: 20130917 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 131101427 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-09-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2013-09-16 4 M 0 7500 18.93 A 151900 D Common Stock 2013-09-16 4 S 0 3085 76.40 D 148815 D Common Stock 2013-09-16 4 S 0 2895 77.44 D 145920 D Common Stock 2013-09-16 4 S 0 1320 78.38 D 144600 D Common Stock 2013-09-16 4 S 0 200 79.08 D 144400 D Common Stock 4770 I 401(k) Common Stock 5568 I Revocable Trust Stock Option 18.93 2013-09-16 4 M 0 7500 0.00 D 2018-02-06 Common Stock 7500 10500 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $76.40 (range $75.97 to $76.93). Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $77.44 (range $76.97 to $77.96). Open market sales reported on this line occurred at a weighted average price of $78.38 (range $78.03 to $78.89). Fully vested. Kenneth L. Horton, Attorney-In-Fact 2013-09-17